Immediate Impact

3 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Natural killer cell therapies
2024 StandoutNature
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
2 intermediate papers

Works of Frederick Lansigan being referenced

Effect of adding ublituximab to ibrutinib on PFS, ORR, and MRD negativity in previously treated high-risk chronic lymphocytic leukemia: Final results of the GENUINE phase III study.
2020
Flavonoids, phenoxodiol, and a novel agent, triphendiol, for the treatment of pancreaticobiliary cancers
2009

Author Peers

Author Last Decade Papers Cites
Frederick Lansigan 452 253 338 282 100 952
Raúl Córdoba 401 235 506 205 126 1.1k
Atsushi Oyama 400 127 309 199 73 1.0k
Burhan Ferhanoğlu 495 250 442 104 77 1.1k
Min Kyoung Kim 230 100 380 126 86 1.1k
Carlos Chiattone 292 488 269 130 97 1.1k
Sheng Yang 277 66 392 187 104 748
Nobuhiro Kanemura 343 100 322 199 69 1.0k
Jean L. Koff 421 191 415 124 61 943
Ru Feng 357 254 311 122 90 942
Huiqiang Huang 307 73 334 147 77 777

All Works

Loading papers...

Rankless by CCL
2026